Our existential flight from death – and wisdom on connecting to grief
Could you count on your fingers the number of corpses you’ve seen, touched, kissed, or embraced? Death Thought Leader Kevin Toolis challenges us to look past…
Could you count on your fingers the number of corpses you’ve seen, touched, kissed, or embraced? Death Thought Leader Kevin Toolis challenges us to look past…
Lisa Bancroft is among thousands of people who have been tested for the faulty BRCA gene since its discovery 30 years ago.
Join us at HTTR 2024 in Washington, DC, USA, for dynamic sessions that provide a comprehensive look at the molecular mechanisms that drive resistance to…
Zach Klaassen facilitates a conversation on the continuum of care in metastatic hormone-sensitive prostate cancer (mHSPC) with Jason Hafron and Elisabeth Heath. The discussion underscores…
The Excellence in Clinical Endocrinology Leadership (ExCEL) program is now accepting applications. Individuals from diverse backgrounds and underrepresented …
Jason Efstathiou discusses the PARTIQoL trial, a randomized phase III study comparing proton beam therapy to IMRT for localized prostate cancer. Dr. Efstathiou discusses the…
The trust says that alternative car parks will be open as normal for patients and visitors.
About this episode: CRISPR technology can edit genetic codes, making it possible to cure people of terrible diseases, among other uses. But its power is…
Alicia Morgans hosts a discussion with Paul Eber and Brad Somer to explore the collaborative management of metastatic hormone-sensitive prostate cancer cases. They highlight a…
Drs Ryan Law and Juan Carlos Bucobo discuss their Technology Status Evaluation Report, “Submucosal injection fluid and tattoo agents” from the November issue…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Bone Health Management for Advanced Prostate Cancer – Fred Saad Part…